ACHFF (Arch Biopartners) FCF Margin %: 0.00% (As of Mar. 2026)


ACHFF Arch Biopartners Inc ACHFF
26 GF Score
Price $0.64
! 4 Warning Signs
View Full Analysis

What is Arch Biopartners FCF Margin %?

Arch Biopartners ACHFF +5.30% 26 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ACHFF with a GF Score™ of 26/100. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Arch Biopartners ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Arch Biopartners's Free Cash Flow for the three months ended in Mar. 2026 was $-0.08 Mil. Arch Biopartners's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Arch Biopartners's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Arch Biopartners's current FCF Yield % is -1.71%.

The historical rank and industry rank for Arch Biopartners's FCF Margin % or its related term are showing as below:


ACHFF's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Arch Biopartners FCF Margin % Related Terms

Arch Biopartners FCF Margin % Historical Data

* Premium members only.

The historical data trend for Arch Biopartners's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Biopartners FCF Margin % Chart

Arch Biopartners Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Arch Biopartners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ACHFF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Arch Biopartners's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's FCF Margin % falls into.


ACHFF
26GF Score
Arch Biopartners Inc ACHFF
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Biopartners FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Arch Biopartners's FCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-1.145/0
= %

Arch Biopartners's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.079/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Arch Biopartners (ACHFF) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Arch Biopartners and its competitors. According to the industry distribution chart, Arch Biopartners ranks #999999 out of 959 companies in the Biotechnology industry.
Is Arch Biopartners' FCF Margin % too high?
Arch Biopartners' current FCF Margin % is 0.00%. Based on the distribution chart, Arch Biopartners ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Arch Biopartners has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Arch Biopartners' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Arch Biopartners ranks #999999 out of 959 companies for FCF Margin %. This places Arch Biopartners in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Arch Biopartners and its competitors. Arch Biopartners's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Biopartners stock overvalued right now?
Arch Biopartners (ACHFF) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Arch Biopartners' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Arch Biopartners (ACHFF), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Biopartners Business Description

Other Exchanges 8HA:GermanyARCH:Canada
Address 545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
26GF Score

Get the complete analysis for ACHFF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64
Price